The vision of the Center for Clinical and Translational Science and Training (CCTST) at the University of Cincinnati is to be the Greater Cincinnati portal of entry for support of clinical and translational research with a goal to enfranchise stakeholders from a broad base to integrate research into healthcare delivery, improve community wellness, foster effective, efficient multisite trials, and train the clinical and translational research workforce of the future. We will realize this vision through three aims: (1) Empower stakeholders in the process of integrating research with healthcare practice and community wellness, (2) Create the workforce of the future, and (3) Optimize efficiency and effectiveness of clinical research. Building on the successes of the last 6 years, we propose innovative changes to existing programs and creation of new programs designed to provide support for high quality cutting-edge research done by teams of scientists. Building on our existing programs, we propose to (1) provide innovative programs in career development for a wide range of learners, (2) develop new pilot programs to support creation of solutions for obstacles to research, (3) expand our community engagement program to extend beyond Greater Cincinnati to stakeholders across the U.S., (4) provide more comprehensive support by biomedical informatics for the services provided by the CCTST, (5) expand support for patient-oriented research, and (6) help overcome regulatory and ethical challenges that impede clinical research in local and multisite studies. We propose innovative efforts directed toward fostering learning health networks and creating a Research Commons to provide more comprehensive support to investigators. We will focus on (1) teaching and implementing team science principles and encouraging collaboration across a variety of disciplines and stakeholders, (2) consolidation of clinical trials support across the academic health center by creating Cinci-HERO to help multicenter trials for which the CCTST affiliates are the leads (including serving as the IRB of record) or site participants and recruitment of populations across the lifespan including underrepresented minorities, those with environmental exposures and health disparities, and (3) acute care research and lifespan data integration that takes advantage of institutional strengths.

Public Health Relevance

The maturation of the CTSA consortium has led to more effective and efficient clinical and translational research across the 62 sites. The University of Cincinnati Center for Clinical and Translational Science and Training has already been successful at fostering and become the focal point for clinical and translational research in Cincinnati. With this renewal application, we will develop additional innovative methods to produce high quality research, share these discoveries, and collaborate with other CTSA hubs.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
1UL1TR001425-01
Application #
9085664
Study Section
Special Emphasis Panel (ZTR1-SRC (99))
Program Officer
Merchant, Carol
Project Start
2015-08-14
Project End
2019-03-31
Budget Start
2015-08-14
Budget End
2016-03-31
Support Year
1
Fiscal Year
2015
Total Cost
$3,187,599
Indirect Cost
$513,333
Name
University of Cincinnati
Department
Pediatrics
Type
Schools of Medicine
DUNS #
041064767
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Andrew, Melissa; Liao, Lihong; Fujimoto, Masanobu et al. (2018) PAPPA2 as a Therapeutic Modulator of IGF-I Bioavailability: in Vivo and in Vitro Evidence. J Endocr Soc 2:646-656
Kaplan, Jennifer M; Zingarelli, Basilia; Krallman, Kelli et al. (2018) Phase 1 safety and pharmacokinetic study on the use of pioglitazone in critically ill patients with sepsis: a randomized clinical trial. Intensive Care Med 44:2006-2008
Zhang, Xue; Biagini Myers, Jocelyn M; Burleson, J D et al. (2018) Nasal DNA methylation is associated with childhood asthma. Epigenomics 10:629-641
Hall, Eric S; Wexelblatt, Scott L; Greenberg, James M (2018) Surveillance of Intrauterine Opioid Exposures Using Electronic Health Records. Popul Health Manag 21:486-492
AlE'ed, Ashwaq; Aydin, Pinar Ozge Avar; Al Mutairi, Nora et al. (2018) Validation of the Cutaneous Lupus Erythematosus Disease Area and Severity Index and pSkindex27 for use in childhood-onset systemic lupus erythematosus. Lupus Sci Med 5:e000275
Mayer-Hamblett, Nicole; Retsch-Bogart, George; Kloster, Margaret et al. (2018) Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis. The OPTIMIZE Randomized Trial. Am J Respir Crit Care Med 198:1177-1187
Lesmana, Harry; Dyer, Lisa; Li, Xia et al. (2018) Alu element insertion in PKLR gene as a novel cause of pyruvate kinase deficiency in Middle Eastern patients. Hum Mutat 39:389-393
Visconti, Kevin C; DeFranco, Emily; Kamath-Rayne, Beena D (2018) Contemporary practice patterns in the use of amniocentesis for fetal lung maturity. J Matern Fetal Neonatal Med 31:2729-2736
Mendizábal, Brenda; Urbina, Elaine M; Becker, Richard et al. (2018) SHIP-AHOY (Study of High Blood Pressure in Pediatrics: Adult Hypertension Onset in Youth). Hypertension 72:625-631
Hamdani, Gilad; Flynn, Joseph T; Daniels, Stephen et al. (2018) Ambulatory blood pressure monitoring tolerability and blood pressure status in adolescents: the SHIP AHOY study. Blood Press Monit :

Showing the most recent 10 out of 1807 publications